These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33356138)

  • 1. Systematic Structure-Based Virtual Screening Approach to Antibody Selection and Design of a Humanized Antibody against Multiple Addictive Opioids without Affecting Treatment Agents Naloxone and Naltrexone.
    Zhang CH; Kim K; Jin Z; Zheng F; Zhan CG
    ACS Chem Neurosci; 2021 Jan; 12(1):184-194. PubMed ID: 33356138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Methoxynaltrexone is not a selective antagonist for the acute psychomotor stimulating effects of heroin and 6-monoacetylmorphine in mice.
    Eriksen GS; Andersen JM; Boix F; Mørland J
    Pharmacol Biochem Behav; 2014 Jul; 122():82-8. PubMed ID: 24699386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heroin antinociception changed from mu to delta receptor in streptozotocin-treated mice.
    Rady JJ; Gorny JM; Fujimoto JM
    Jpn J Pharmacol; 1998 Dec; 78(4):443-54. PubMed ID: 9920201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine-like discriminative stimulus effects of heroin in squirrel monkeys: role of active metabolites and opioid receptor mechanisms.
    Rowlett JK; Spealman RD; Platt DM
    Psychopharmacology (Berl); 2000 Jun; 150(2):191-9. PubMed ID: 10907672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: Comparison with naltrexone.
    Schwienteck KL; Blake S; Bremer PT; Poklis JL; Townsend EA; Negus SS; Banks ML
    Drug Alcohol Depend; 2019 Nov; 204():107501. PubMed ID: 31479865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss-Webster mice.
    Rady JJ; Aksu F; Fujimoto JM
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1222-31. PubMed ID: 8138935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine.
    Selley DE; Cao CC; Sexton T; Schwegel JA; Martin TJ; Childers SR
    Biochem Pharmacol; 2001 Aug; 62(4):447-55. PubMed ID: 11448454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication Treatment of Opioid Use Disorder.
    Bell J; Strang J
    Biol Psychiatry; 2020 Jan; 87(1):82-88. PubMed ID: 31420089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody specific for 6-monoacetylmorphine reduces acute heroin effects in mice.
    Bogen IL; Boix F; Nerem E; Mørland J; Andersen JM
    J Pharmacol Exp Ther; 2014 Jun; 349(3):568-76. PubMed ID: 24700886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys.
    Bowen CA; Fischer BD; Mello NK; Negus SS
    J Pharmacol Exp Ther; 2002 Jul; 302(1):264-73. PubMed ID: 12065726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A morphine/heroin vaccine with new hapten design attenuates behavioral effects in rats.
    Li QQ; Luo YX; Sun CY; Xue YX; Zhu WL; Shi HS; Zhai HF; Shi J; Lu L
    J Neurochem; 2011 Dec; 119(6):1271-81. PubMed ID: 21951213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Effects of a Monoclonal Antibody against 6-Monoacetylmorphine upon Heroin-Induced Locomotor Activity and Pharmacokinetics in Mice.
    Kvello AM; Andersen JM; Øiestad EL; Mørland J; Bogen IL
    J Pharmacol Exp Ther; 2016 Aug; 358(2):181-9. PubMed ID: 27217591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal Antibodies Counteract Opioid-Induced Behavioral and Toxic Effects in Mice and Rats.
    Baehr C; Kelcher AH; Khaimraj A; Reed DE; Pandit SG; AuCoin D; Averick S; Pravetoni M
    J Pharmacol Exp Ther; 2020 Dec; 375(3):469-477. PubMed ID: 32980813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats.
    Raleigh MD; Pravetoni M; Harris AC; Birnbaum AK; Pentel PR
    J Pharmacol Exp Ther; 2013 Feb; 344(2):397-406. PubMed ID: 23220743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Use Disorders.
    Sharma B; Bruner A; Barnett G; Fishman M
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):473-87. PubMed ID: 27338968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice.
    Eriksen GS; Andersen JM; Boix F; Bergh MS; Vindenes V; Rice KC; Huestis MA; Mørland J
    J Pharmacol Exp Ther; 2016 Aug; 358(2):209-15. PubMed ID: 27278234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 6-monoacetylmorphine in the acute release of striatal dopamine induced by intravenous heroin.
    Gottås A; Boix F; Øiestad EL; Vindenes V; Mørland J
    Int J Neuropsychopharmacol; 2014 Sep; 17(9):1357-65. PubMed ID: 24576415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol.
    Dennis BB; Naji L; Bawor M; Bonner A; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Samaan Z; Thabane L
    Syst Rev; 2014 Sep; 3():105. PubMed ID: 25239213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.